Noble Financial analyst Robert LeBoyer reiterated a Buy rating on Cadrenal Therapeutics, Inc. (CVKD – Research Report) today and set a price ...
Stock analysts at Noble Financial issued their FY2024 earnings per share (EPS) estimates for Gyre Therapeutics in a research report issued to clients and investors on Tuesday, March 11th. Noble ...
Company insiders are ditching their own stock more than usual. An exception is oil and gas executives, some of whom are ...
As part of its longstanding commitment to social responsibility and supporting those in need, Petrolina proudly sponsors the ...
As Barnes & Noble continues to experience recent growth of its stores, the latest will open in Prince William County.
Return of former board member Lip-Bu Tan sends shares in US chip group 11% higher in post-market trading ...
Stock analysts at Noble Financial raised their Q2 2026 earnings per share (EPS) estimates for AZZ in a research note issued ...